Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

sell
Merck KGaA

Start price
Target price
Perf. (%)
€124.80
23.09.20
-
04.11.21
4.17%
25.11.20

ROE higher than 10% per year
Low dividend yield expected
NightTrain 
23.09.20 50%
buy
WAVE Life Sciences Ltd

Start price
Target price
Perf. (%)
€8.90
23.09.20
-
26.10.20
-25.84%
26.10.20

Could be very worthwhile Investment >20% year
Biotechhunter 
23.09.20 50%
buy
Horizon Pharma plc

Start price
Target price
Perf. (%)
€71.00
23.09.20
-
26.10.20
-7.82%
26.10.20

Could be very worthwhile Investment >20% year
Biotechhunter 
23.09.20 50%
sell
Inovio Pharma

Start price
Target price
Perf. (%)
€13.60
23.09.20
-
26.10.20
-31.99%
26.10.20

Risky Investment
Biotechhunter 
23.09.20 50%
buy
Evotec SE

Start price
Target price
Perf. (%)
€23.43
23.09.20
€36.00
04.11.21
58.26%
21.06.21

Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
Fair valuation
High Investments for future growth
Mori8 
23.09.20 50%
sell
AstraZeneca plc

Start price
Target price
Perf. (%)
€94.00
22.09.20
€78.00
04.11.21
-0.76%
07.06.21

Subdi 
22.09.20 50%
buy
Novartis AG ADR

Start price
Target price
Perf. (%)
€75.50
21.09.20
€90.00
04.11.21
-3.84%
05.11.21

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
skatcup 
21.09.20 70%
buy
Sorrento Therapeutics Inc.

Start price
Target price
Perf. (%)
€8.17
21.09.20
€12.00
02.11.20
-24.15%
02.11.20

Could be very worthwhile Investment >20% year
Very Future proof/growth oriented business model
Top 10 in its market
Leading role in innovation
yester 
21.09.20 50%
sell
Edesa Biotech Inc

Start price
Target price
Perf. (%)
€6.15
21.09.20
€4.00
04.11.21
17.07%
05.11.21

Probably not worthwhile Investment
High valuation
yester 
21.09.20 50%
buy
Sangamo Therapeutics Inc.

Start price
Target price
Perf. (%)
€8.92
20.09.20
-
04.11.21
6.78%
05.11.21

Could be worthwhile Investment >10% per year
Very low/no dividend yield expected
Maxfloh 
20.09.20 50%
buy
Novartis AG ADR

Start price
Target price
Perf. (%)
€77.00
19.09.20
-
04.11.21
3.25%
22.01.21

Could be very worthwhile Investment >20% year
Known brand
Significant cyclical dependencies
tinelchen 
19.09.20 50%
buy
Novavax Inc.

Start price
Target price
Perf. (%)
€91.29
19.09.20
-
04.11.21
16.11%
27.11.20

Could be worthwhile Investment >10% per year
Future proof or reliable business model
tinelchen 
19.09.20 50%
buy
Immunomedics Inc.

Start price
Target price
Perf. (%)
€72.02
19.09.20
-
04.11.21
3.10%
05.11.21

Could be worthwhile Investment >10% per year
PlusUltra 
19.09.20 50%
buy
Sorrento Therapeutics Inc.

Start price
Target price
Perf. (%)
€8.00
19.09.20
-
04.11.21
-26.89%
05.11.21

Could be worthwhile Investment >10% per year
PlusUltra 
19.09.20 50%
buy
Medigene AG

Start price
Target price
Perf. (%)
€4.63
16.09.20
€6.00
21.09.20
-4.54%
21.09.20

Could be worthwhile Investment >10% per year
DomRuinart 
16.09.20 50%
buy
Vaxart Inc.

Start price
Target price
Perf. (%)
€4.22
09.09.20
€8.00
04.11.21
42.75%
05.11.21

Could be worthwhile Investment >10% per year
melinda 
09.09.20 50%
buy
Corbus Pharmaceuticals Holding Inc.

Start price
Target price
Perf. (%)
€47.63
08.09.20
-
19.09.20
-4.25%
19.09.20

Could be worthwhile Investment >10% per year
Very bad culture
No uniques
Below average Management
me8 
08.09.20 50%
buy
Hexo Corp.

Start price
Target price
Perf. (%)
€31.77
08.09.20
€56.00
04.11.21
-45.36%
05.11.21

Could be worthwhile Investment >10% per year
Fair valuation
Top 10 in its market
yester 
08.09.20 50%
buy
Sorrento Therapeutics Inc.

Start price
Target price
Perf. (%)
€5.60
08.09.20
€7.00
21.09.20
46.07%
21.09.20

Could be very worthwhile Investment >20% year
Very Future proof/growth oriented business model
Top 10 in its market
Leading role in innovation
yester 
08.09.20 50%
sell
Trillium Therapeutics

Start price
Target price
Perf. (%)
€8.28
07.09.20
-
04.11.21
-21.91%
15.07.21

Could be very worthwhile Investment >20% year
Biotechhunter 
07.09.20 50%
buy
Mallinckrodt plc

Start price
Target price
Perf. (%)
€1.28
07.09.20
€1.40
14.09.20
-28.98%
14.09.20

Risky Investment
Global_Player 
07.09.20 50%
sell
Cti Biopharma Corp

Start price
Target price
Perf. (%)
€0.84
06.09.20
-
19.09.20
16.17%
19.09.20

DrMabuse 
06.09.20 50%
buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€128.00
06.09.20
€125.00
04.11.21
-3.25%
06.11.20

Future proof or reliable business model
Higher risks for its business
Risky Investment
phonebroker 
06.09.20 50%
buy
Verastem Inc.

Start price
Target price
Perf. (%)
€11.94
06.09.20
€24.00
28.09.20
7.41%
28.09.20

Could be very worthwhile Investment >20% year
Fair valuation
Increased challenges to pay loans and raise capital
Risky balance sheet
dimontalban 
06.09.20 50%
buy
Novavax Inc.

Start price
Target price
Perf. (%)
€80.99
05.09.20
-
04.11.21
74.71%
03.06.21

Could be very worthwhile Investment >20% year
secretariat 
05.09.20 50%